A Study to Test How Well Healthy Men Tolerate BI 765250 When Given as an Infusion Into the Vein or as an Injection Under the Skin
Clinical trial NCT05151653 · COMPLETED
Trial details
- NCT number
- NCT05151653
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-26
- Primary completion
- 2024-09-13
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.